Category: Europe

February 27, 2017 Off

Exelixis and BMS to evaluate cancer drug combination

By Dino Mustafić

Exelixis and Bristol-Myers Squibb have entered into a clinical development collaboration to evaluate Cabometyx (cabozantinib), Exelixis’ small molecule inhibitor of receptor tyrosine kinases, with Opdivo (nivolumab), Bristol-Myers Squibb’s PD-1 immune checkpoint inhibitor, either alone or in combination with Yervoy (ipilimumab).

February 27, 2017 Off

Former Pfizer, current Centrexion CEO joins Israel’s Pharma Two B’s board of directors after leading $30M worth third financing round

By Dino Mustafić

Former Pfizer CEO and chairman Jeff Kindler will be joining privately held Israel’s drugmaker Pharma Two B’s board of directors, as the company completed its third round of financing, raising $30 million, with Israel Biotech Fund (IBF) leading the procedure. Jeff Kindler is a member of Israel Biotech Fund’s Venture Advisory Team.